You are here » Home » Companies » Company Overview » Caplin Point Laboratories Ltd

Caplin Point Laboratories Ltd.

BSE: 524742 Sector: Health care
NSE: CAPLIPOINT ISIN Code: INE475E01026
BSE LIVE 15:40 | 23 Jun 581.40 5.90
(1.03%)
OPEN

581.00

HIGH

599.00

LOW

570.05

NSE 15:48 | 23 Jun 581.35 4.15
(0.72%)
OPEN

583.30

HIGH

599.80

LOW

575.00

OPEN 581.00
PREVIOUS CLOSE 575.50
VOLUME 23638
52-Week high 630.00
52-Week low 188.00
P/E 61.98
Mkt Cap.(Rs cr) 4,395
Buy Price 581.40
Buy Qty 200.00
Sell Price 0.00
Sell Qty 0.00
OPEN 581.00
CLOSE 575.50
VOLUME 23638
52-Week high 630.00
52-Week low 188.00
P/E 61.98
Mkt Cap.(Rs cr) 4,395
Buy Price 581.40
Buy Qty 200.00
Sell Price 0.00
Sell Qty 0.00

Caplin Point Laboratories Ltd. (CAPLIPOINT) - Company History

Incorporated in Apr.'90, Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders. The company came out with a public issue in Nov.'94 and expanded its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry. The company has retained its SSI status even after the expansion and thus will be out of the purview of the DPCO. During 1993-94, Triwin (a partnership firm) was merged with Caplin Point. The company entered into a technical agreement with American Remedies, US, and Concord Laboratories, US, for specific products, with a 30% buyback arrangement. It also imports bio-technological products to market them in India. The company has established a trading branch in Nairobi, Kenya, to sell its products in East Africa. It has also established a warehouse in Miami, US, by entering into a marketing tie-up with Lockett Medical Corporation, US.